Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

Aktiia announced today that it raised an oversubscribed $42 million Series B funding round and introduced its new "Hilo" ...

Rhythm Technologies (Nasdaq: IRTC) shares are on the rise on first-quarter results that were mixed compared to the Wall ...

ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix  (Nasdaq:NURO ...

Inquis Medical today announced findings from the AVENTUS trial evaluating the safety and efficacy of its Aventus thrombectomy ...

Baxter EVP and CFO Joel Grade said some tariff mitigation activities are underway while others are being developed.

The company reports that NUOS 3 can enable patients who have been declared clinically dead — at times for over 30 minutes — and later resuscitated to regain the ability to communicate. Despite ...